Standard

Thrombosis: a major contributor to global disease burden. / Raskob, G. E.; Angchaisuksiri, P.; Blanco, A. N. et al.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 34, No. 11, 2014, p. 2363-2371.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

Raskob, GE, Angchaisuksiri, P, Blanco, AN, Buller, H, Gallus, A, Hunt, BJ, Hylek, EM, Kakkar, A, Konstantinides, SV, McCumber, M, Ozaki, Y, Wendelboe, A & Weitz, JI 2014, 'Thrombosis: a major contributor to global disease burden', Arteriosclerosis, thrombosis, and vascular biology, vol. 34, no. 11, pp. 2363-2371. https://doi.org/10.1161/ATVBAHA.114.304488

APA

Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H., Gallus, A., Hunt, B. J., Hylek, E. M., Kakkar, A., Konstantinides, S. V., McCumber, M., Ozaki, Y., Wendelboe, A., & Weitz, J. I. (2014). Thrombosis: a major contributor to global disease burden. Arteriosclerosis, thrombosis, and vascular biology, 34(11), 2363-2371. https://doi.org/10.1161/ATVBAHA.114.304488

Vancouver

Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ et al. Thrombosis: a major contributor to global disease burden. Arteriosclerosis, thrombosis, and vascular biology. 2014;34(11):2363-2371. https://doi.org/10.1161/ATVBAHA.114.304488

Author

Raskob, G. E. ; Angchaisuksiri, P. ; Blanco, A. N. et al. / Thrombosis: a major contributor to global disease burden. In: Arteriosclerosis, thrombosis, and vascular biology. 2014 ; Vol. 34, No. 11. pp. 2363-2371.

BibTeX

@article{fecebd28c6aa4a009d94fb06ee7fe041,
title = "Thrombosis: a major contributor to global disease burden",
abstract = "Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. To review the literature on the global burden of disease caused by VTE. We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted life-years lost in low- and middle-income countries, and second in high-income countries, responsible for more disability-adjusted life-years lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems and to evaluate whether improved use of preventive measures will reduce the burden",
author = "Raskob, {G. E.} and P. Angchaisuksiri and Blanco, {A. N.} and H. Buller and A. Gallus and Hunt, {B. J.} and Hylek, {E. M.} and A. Kakkar and Konstantinides, {S. V.} and M. McCumber and Y. Ozaki and A. Wendelboe and Weitz, {J. I.}",
year = "2014",
doi = "10.1161/ATVBAHA.114.304488",
language = "English",
volume = "34",
pages = "2363--2371",
journal = "Arteriosclerosis, thrombosis, and vascular biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - Thrombosis: a major contributor to global disease burden

AU - Raskob, G. E.

AU - Angchaisuksiri, P.

AU - Blanco, A. N.

AU - Buller, H.

AU - Gallus, A.

AU - Hunt, B. J.

AU - Hylek, E. M.

AU - Kakkar, A.

AU - Konstantinides, S. V.

AU - McCumber, M.

AU - Ozaki, Y.

AU - Wendelboe, A.

AU - Weitz, J. I.

PY - 2014

Y1 - 2014

N2 - Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. To review the literature on the global burden of disease caused by VTE. We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted life-years lost in low- and middle-income countries, and second in high-income countries, responsible for more disability-adjusted life-years lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems and to evaluate whether improved use of preventive measures will reduce the burden

AB - Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. To review the literature on the global burden of disease caused by VTE. We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted life-years lost in low- and middle-income countries, and second in high-income countries, responsible for more disability-adjusted life-years lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems and to evaluate whether improved use of preventive measures will reduce the burden

U2 - 10.1161/ATVBAHA.114.304488

DO - 10.1161/ATVBAHA.114.304488

M3 - Article

C2 - 25304324

VL - 34

SP - 2363

EP - 2371

JO - Arteriosclerosis, thrombosis, and vascular biology

JF - Arteriosclerosis, thrombosis, and vascular biology

SN - 1079-5642

IS - 11

ER -

ID: 2489147